Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 2.29M | 4.86M | 2.31M | 2.71M | 2.68M | 2.35M |
Gross Profit | 2.19M | 4.27M | 2.31M | 2.53M | 2.68M | 2.35M |
EBITDA | 592.00K | 1.82M | 256.00K | 615.00K | -256.00K | 1.70M |
Net Income | 253.00K | 984.00K | 84.00K | 485.00K | -334.00K | 1.26M |
Balance Sheet | ||||||
Total Assets | 8.32M | 15.47M | 8.59M | 8.96M | 9.02M | 4.44M |
Cash, Cash Equivalents and Short-Term Investments | 2.33M | 2.68M | 2.63M | 4.58M | 4.72M | 609.00K |
Total Debt | 294.00K | 2.99M | 371.00K | 311.00K | 385.00K | 1.49M |
Total Liabilities | 778.00K | 5.46M | 1.00M | 1.06M | 1.03M | 2.22M |
Stockholders Equity | 7.54M | 10.02M | 7.59M | 7.89M | 7.99M | 2.21M |
Cash Flow | ||||||
Free Cash Flow | 11.00K | 1.35M | -206.00K | 1.10M | 897.00K | 795.00K |
Operating Cash Flow | 70.00K | 1.41M | -156.00K | 1.15M | 934.00K | 811.00K |
Investing Cash Flow | -488.00K | -3.58M | -1.23M | -43.00K | -37.00K | -16.00K |
Financing Cash Flow | -416.00K | 2.22M | -566.00K | -1.24M | 3.22M | -528.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | £193.48M | 22.51 | 45.84% | 2.97% | 13.00% | 11.16% | |
77 Outperform | £14.58M | 13.36 | 11.18% | 3.02% | 110.08% | 1105.56% | |
77 Outperform | £148.46M | 13.04 | 11.37% | 2.63% | 5.40% | 19.01% | |
71 Outperform | ¥267.71B | 14.94 | 8.32% | 2.77% | 6.08% | 11.04% | |
64 Neutral | £183.58M | 29.17 | 7.85% | 3.55% | 12.41% | 330.43% | |
63 Neutral | £217.42M | ― | -28.97% | 3.47% | 7.76% | -60.70% | |
46 Neutral | £17.54M | ― | -106.45% | ― | -14.04% | 24.84% |
DSW Capital PLC has granted nominal cost options over 738,596 ordinary shares to certain executive directors under its Performance Share Plan. This move underscores the company’s commitment to incentivizing its leadership team, potentially enhancing its operational effectiveness and market positioning in the professional services industry.
DSW Capital reported record financial results for the year ending March 2025, driven by the acquisition of DR Solicitors and high M&A activity. Revenue increased by 62% to £25.8 million, and adjusted EBITDA nearly tripled to £1.787 million. The integration of DR Solicitors has diversified the company’s income, reducing its dependency on M&A. The company remains optimistic about future growth, supported by a strong recruitment pipeline and strategic focus on expanding its mid-market presence.
DSW Capital PLC is set to hold an online presentation for investors and analysts on 10 July 2025, as part of its FY25 Results roadshow. The presentation, led by key executives, will cover the Group’s trading and performance for the year ending 31 March 2025, followed by a Q&A session. This event underscores DSW Capital’s commitment to transparency and engagement with stakeholders, highlighting its strategic focus on growth and market positioning.
DSW Capital has announced a significant upgrade to its FY25 guidance, driven by exceptional M&A performance and the acquisition of DR Solicitors. The company’s FY25 revenue and Adjusted EBITDA have surpassed market forecasts, with network revenue expected to rise by 61% to £25.8m and Adjusted EBITDA nearly tripling to £1.76m. The acquisition of DR Solicitors has strengthened DSW’s legal platform, contributing to a more balanced business model with reduced reliance on M&A revenues. The company is optimistic about future growth, despite potential market disruptions, and plans to continue diversifying and expanding its services.